Elevated citrate in pediatric astrocytomas with malignant progression

Neuro-Oncology

Volumn 13, Issue 10, 2011, Pages 1107-1117

  Blüml, Stefan ^a,b   Panigrahy, Ashok ^a,c   Laskov, Mikhail ^a,d   Dhall, Girish ^a   Krieger, Mark D ^a   Nelson, Marvin D ^a   Finlay, Jonathan L ^a   Gilles, Floyd H ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b Rudi Schulte Research Institute   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Astrocytoma; Citrate; Metabolism; MR spectroscopy; Pediatrics

Indexed keywords

CITRIC ACID;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CHILD; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CITRIC ACID; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RETROSPECTIVE STUDIES;

EID: 80755125609     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nor087     Document Type: Article

References (56)

1. Seymour ZA, Panigrahy A, Finlay JL, Nelson MD, Jr, Bluml S. Citrate in pediatric CNS tumors? AJNR Am J Neuroradiol. 2008;29(5):1006-1011. (Pubitemid 351684985)
2. Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309- 314.
3. Busch H, Davis JR, Olle EW. Citrate accumulation in slices of transplantable tumors of the rat. Cancer Res. 1957;17(7):711-716.
4. Vander Heiden M, Cantley L, Thompson C. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029- 1033.
5. Farmer JP, Montes JL, Freeman CR, Meagher-Villemure K, Bond MC, O'Gorman AM. Brainstem Gliomas. A 10-year institutional review. Pediatr Neurosurg. 2001;34(4):206-214. (Pubitemid 32453752)
6. Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys. 1998;40(2):265-271. (Pubitemid 28114367)
7. Mandell LR, Kadota R, Freeman C, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;43(5):959-964. (Pubitemid 29144779)
8. Pan E, Prados M. Brainstem Gliomas. In: Gupta, N, Haas-Kogen, D, Banerjee, A, eds. Pediatric CNS Tumors. Vol 3. Berlin/Heidelberg/New York: Springer; 2004:49-61.
9. Nelson MD, Jr, Soni D, Baram TZ. Necrosis in pontine gliomas: radiation induced or natural history? Radiology. 1994;191(1):279-282. (Pubitemid 24098246)
10. Yoshimura J, Onda K, Tanaka R, Takahashi H. Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases. Neurol Med Chir. (Tokyo). 2003;43(8):375-382; discussion 382. (Pubitemid 37071218)
11. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006;7(3):241-248. (Pubitemid 43286454)
12. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205-216.
13. Panigrahy A, Krieger MD, Gonzalez-Gomez I, et al. Quantitative Short Echo Time 1H-MR Spectroscopy of Untreated Pediatric Brain Tumors: Preoperative Diagnosis and Characterization. AJNR Am J Neuroradiol. 2006;27(3):560-572. (Pubitemid 44897775)
14. Kovanlikaya A, Panigrahy A, Krieger M, et al. Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. Radiology. 2005;236(3):1020-1025. (Pubitemid 41170867)
15. Panigrahy A, Nelson MD, Jr, Finlay JL, et al. Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol. 2008;10(1):32-44. (Pubitemid 351250898)
16. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2003;49(2):223-232. (Pubitemid 36159858)
17. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg. 1996;84(3):449-458. (Pubitemid 26062870)
18. Stadlbauer A, Gruber S, Nimsky C, et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology. 2006;238(3):958-969. (Pubitemid 43289928)
19. Brown WD, Gilles FH, Tavare CJ, et al. Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors. J Neuropathol Exp Neurol. 1998;57(11):1035-1040. (Pubitemid 28525450)
20. Gilles FH, Brown WD, Leviton A, et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium. Cancer. 2000;88(6):1477-1483. (Pubitemid 30155188)
21. Reitman Z, Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst. 2010;102(13):932-941.
22. Gilles F, Tavaré C, Leviton A, et al. Prognostic limitations of the Daumas-Duport grading scheme in infratentorial neuroglial tumors in children. Pediatr Dev Pathol. 2004;7(2):138-147. (Pubitemid 38715333)
23. Yan H, Bigner D, Velculescu V, Parsons D. Mutant metabolic enzymes are at the origin of gliomas. Cancer Res. 2009;69(24):9157-9159.
24. Dóczi T, Schwarcz A. Correlation of apparent diffusion coefficient and computed tomography density in acute ischemic stroke. Stroke. 2003;34(5):e17-e18; author reply e17-e18.
25. Murakami R, Sugahara T, Nakamura H, et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology. 2007;243(2):493-499. (Pubitemid 46649706)
26. Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology. 2006;241(3):839-846. (Pubitemid 46190551)
27. Chen HJ, Panigrahy A, Dhall G, Finlay JL, Nelson MD, Blüml S. Apparent diffusion and fractional anisotropy of diffuse intrinsic brain stem gliomas. AJNR Am J Neuroradiol. 2010;31(10):1879-1885.
28. Parsons D, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807-1812.
29. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol. 2009;174(4):1149-1153.
30. Zhao S, Lin Y, Xu W, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science. 2009;324(5924):261-265.
31. Yan H, Parsons D, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360(8):765-773.
32. Dang L, White D, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2010;465(7300):966.
33. Beckner M, Fellows-Mayle W, Zhang Z, et al. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas. Int J Cancer. 2010;126(10):2282-2295.
34. Denko N. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008;8(9):705-713.
35. Milosevic M, Fyles A, Hedley D, Hill R. The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure. Semin Radiat Oncol. 2004;14(3):249-258. (Pubitemid 38903229)
36. Jain R, Baxter L. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 1988;48(24 Pt 1):7022-7032. (Pubitemid 19013976)
37. Tong R, Boucher Y, Kozin S, Winkler F, Hicklin D, Jain R. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 2004;64(11):3731-3736. (Pubitemid 38697278)
38. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93(4):266-276. (Pubitemid 32219813)
39. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56(19):4509-4515. (Pubitemid 26330463)
40. Hockel M, Schlenger K, Mitze M, Schaffer U, Vaupel P. Hypoxia and Radiation Response in Human Tumors. Semin Radiat Oncol. 1996;6(1):3-9. (Pubitemid 26029370)
41. Sutherland RM, Ausserer WA, Murphy BJ, Laderoute KR. Tumor Hypoxia and Heterogeneity: Challenges and Opportunities for the Future. Semin Radiat Oncol. 1996;6(1):59-70. (Pubitemid 26029374)
42. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8(8):610-622. (Pubitemid 47093931)
43. Winkler F, Kozin SV, Tong RT, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. 2004;6(6):553-563. (Pubitemid 40017699)
44. Baslow MH. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease. Journal of Molecular Neuroscience. 2000;15(2):61-69. (Pubitemid 32108676)
45. Tallan HH. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem. 1957;224(1):41-45.
46. Ackerstaff E, Glunde K, Bhujwalla ZM. Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem. 2003;90(3):525-533. (Pubitemid 37243700)
47. Podo F. Tumour phospholipid metabolism. NMR Biomed. 1999;12(7):413-439. (Pubitemid 30016999)
48. Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS, Jr. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol. 1998;19(3):535-540. (Pubitemid 30422765)
49. Negendank W, Sauter R. Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. Anticancer Res. 1996;16(3 B):1533-1538. (Pubitemid 26257823)
50. Negendank WG. Studies of human tumors by MRS: a review. NMR in Biomedicine. 1992;5:303-324.
51. Thakur SB, Karimi S, Dunkel IJ, Koutcher JA, Huang W. Longitudinal MR Spectroscopic Imaging of Pediatric Diffuse Pontine Tumors to Assess Tumor Aggression and Progression. AJNR Am J Neuroradiol. 2006;27(4):806-809. (Pubitemid 44897726)
52. Laprie A, Pirzkall A, Haas-Kogan DA, et al. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62(1):20-31. (Pubitemid 40591919)
53. Li BS, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging. 2003;21(8):923-928. (Pubitemid 37377485)
54. Shimizu H, Kumabe T, Shirane R, Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol. 2000;21(4):659-665. (Pubitemid 30210427)
55. Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology. 2000;42(5):333-338. (Pubitemid 30265348)
56. Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg. 1997;87(4):516-524. (Pubitemid 27430397)